Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stoke Therapeutics Inc (STOK)
NASDAQ:STOK
RESEARCH TOOLSreports
Stoke Therapeutics (STOK) Ownership Overview
45.88% Insiders
10.74% Mutual Funds
2.55% Other Institutional Investors
11.52% ETFs
29.31% Public Companies and Individual Investors
The ownership structure of Stoke Therapeutics (STOK) stock is a mix of institutional, retail, and individual investors. Approximately 24.81% of the company’s stock is owned by Institutional Investors, 45.88% is owned by Insiders, and 29.31% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 27, 2024 | Skorpios Trust >10% Owner | xxxxxxxxxxxxx | $23000000 |
| Dec 11, 2024 | Edward Kaye Ceo,director | xxxxxxxxxxxxx | $88150 |
| Dec 11, 2024 | Barry Ticho Cmo | xxxxxxxxxxxxx | $33592 |
| Dec 11, 2024 | Jonathan Allan Gc & Corp Sec | xxxxxxxxxxxxx | $20160 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 17,161,713 | Insider | 32.40% | 183,287,095 | |
| 6,906,181 | Insider | 13.04% | 73,758,013 | |
| 4,633,838 | Institution | 8.75% | 49,489,390 | |
| 2,487,944 | Institution | 4.70% | 26,571,242 | |
| 2,160,143 | Institution | 4.08% | 23,070,327 | |
| 1,808,788 | Institution | 3.41% | 19,317,856 | |
| 969,368 | Institution | 1.83% | 10,352,850 | |
| 799,685 | Institution | 1.51% | 8,540,636 | |
| 403,800 | Institution | 0.76% | 4,312,584 | |
| 390,274 | Institution | 0.74% | 4,168,126 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,160,143 | Institution | 4.08% | 23,070,327 | |
| 969,368 | Institution | 1.83% | 10,352,850 | |
| 403,800 | Institution | 0.76% | 4,312,584 | |
| 390,274 | Institution | 0.74% | 4,168,126 | |
| 316,170 | Institution | 0.60% | 3,376,696 | |
| 202,463 | Institution | 0.38% | 2,162,305 | |
| 141,688 | Institution | 0.27% | 1,513,228 | |
| 126,220 | Institution | 0.24% | 1,348,030 | |
| 117,014 | Institution | 0.22% | 1,249,710 | |
| 112,483 | Institution | 0.21% | 1,201,318 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,574,196 | Institution | 2.97% | 17,363,382 | |
| 973,255 | Institution | 1.84% | 10,394,363 | |
| 719,724 | Institution | 1.36% | 7,650,666 | |
| 592,242 | Institution | 1.12% | 6,532,429 | |
| 319,235 | Institution | 0.60% | 3,409,430 | |
| 256,179 | Institution | 0.48% | 2,735,992 | |
| 189,063 | Institution | 0.36% | 2,009,740 | |
| 169,511 | Institution | 0.32% | 1,869,706 | |
| 127,331 | Institution | 0.24% | 1,353,529 | |
| 122,925 | Institution | 0.23% | 1,306,693 |
FAQ
Who Owns Stoke Therapeutics Inc (STOK)?
According to the latest TipRanks data, approximately 2.55% of the company's stock is held by institutional investors, 45.88% is held by insiders, and 29.31% is held by retail investors.
What percentage of Stoke Therapeutics Inc (STOK) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.55% of Stoke Therapeutics Inc (STOK) stock is held by institutional investors.
What percentage of Stoke Therapeutics Inc (STOK) stock is held by retail investors?
According to the latest TipRanks data, approximately 29.31% of Stoke Therapeutics Inc (STOK) stock is held by retail investors.
Who owns the most shares of Stoke Therapeutics Inc (STOK)?
Seth Loring Harrison owns the most shares of Stoke Therapeutics Inc (STOK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.